玻璃体视网膜淋巴瘤诊断与管理的挑战——临床与基础方法
玻璃体视网膜淋巴瘤(VRL)是弥漫性大B细胞淋巴瘤亚型,可危及视力与生命。玻璃体活检组织病理学是诊断金标准,但细胞学检查成功率低。综述讨论光学相干断层扫描、眼底自发荧光、流式细胞术、免疫球蛋白基因重排、细胞因子及基因突变等诊断方法,以及局部和全身治疗现状。
要点
- 玻璃体混浊和奶油白色视网膜下病灶可提示VRL,但表现非特异,易误诊为葡萄膜炎。
- 玻璃体活检组织病理学发现恶性细胞是诊断VRL的金标准,但细胞学检查成功率常较低。
- 局部放疗和/或玻璃体腔注射甲氨蝶呤或利妥昔单抗可有效抑制眼内VRL病灶。
核心结论
- 玻璃体视网膜淋巴瘤(VRL)是弥漫性大B细胞淋巴瘤亚型,在绝大多数患者中危及视力与生命。
- 眼内体征可提示VRL但非特异,可能被误诊为葡萄膜炎。
- 玻璃体活检组织病理学发现恶性细胞是诊断VRL的金标准,但细胞学检查常因样本组织和细胞数量少、质量差而成功率低。
- 局部放疗和/或玻璃体腔注射抗肿瘤药(甲氨蝶呤或利妥昔单抗)可有效抑制眼内VRL病灶,而全身化疗联用或不联用脑部放疗对预防中枢神经系统受累的效果仍有争议。
研究设计与样本
- 综述文章,基于既往文献与作者未发表结果讨论VRL的诊断与治疗。
主要发现
- 眼内体征如玻璃体混浊和奶油白色视网膜下病灶可作为怀疑VRL的线索,但表现非特异。
- 玻璃体活检组织病理学是诊断VRL的金标准,但细胞学检查成功率常较低。
- 近期眼内样本的免疫学、分子和基因分析进展使准确诊断VRL成为可能。
- 局部放疗和/或玻璃体腔注射甲氨蝶呤或利妥昔单抗可有效抑制眼内VRL病灶。
- 全身化疗联用或不联用脑部放疗对预防中枢神经系统受累的效果仍有争议。
关键数值与推荐
- 玻璃体活检组织病理学发现恶性细胞是诊断VRL的金标准。
- 眼内样本的免疫学、分子和基因分析可用于准确诊断VRL。
- 局部治疗包括放疗和/或玻璃体腔注射甲氨蝶呤或利妥昔单抗。
- 综述讨论的诊断方法包括光学相干断层扫描、眼底自发荧光、流式细胞术、聚合酶链反应免疫球蛋白基因重排检测、细胞因子检测及MYD88、CD79B基因突变。
局限性
- 玻璃体细胞学检查常因样本中组织和细胞数量少、质量差而导致成功率低。
- 全身化疗联用或不联用脑部放疗对预防中枢神经系统受累的效果仍有争议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitreoretinal lymphoma (VRL) is a subtype of diffuse large B-cell lymphoma and is sight- and life-threatening in the vast majority of patients. Lymphoma cells infiltrate the vitreous body and/or subretinal space and exhibit clinical signs of vitreous opacities and creamy white subretinal lesions. Although the intraocular signs can serve as clues to suspect VRL, they are nonspecific and may be misdiagnosed as uveitis. Histopathological evidence of malignant cells on vitreous biopsy, for instance, is the gold standard for diagnosis of VRL; however, cytological examination of the vitreous often results in a low success rate owing to the small quantity and poor quality of tissues and cells in the sample. Recent advancements in immunological, molecular, and gene analyses using intraocular samples have made it possible to accurately diagnose VRL. As for the management of VRL, local treatments with irradiation and/or intravitreal injections of anti-tumor agents (methotrexate or rituximab) are effective in suppressing intraocular VRL lesions. However, the effect of systemic chemotherapy, with or without brain irradiation, on preventing central nervous system involvements remains controversial. In this review article, we discuss the following concepts based on previous literature and our unpublished results: current ocular imaging examinations such as optical coherence tomography and fundus autofluorescence; immunological, molecular, and gene expression characterization of intraocular biopsies with special attention to flow cytometry; immunoglobulin gene rearrangement assays that use the polymerase chain reaction test; cytokine assays; gene mutations (MYD88, CD79B); and current local and systemic treatments of VRL.
引用
- Takase H, Arai A, Iwasaki Y, et al. Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches. Prog Retin Eye Res. 2022. PMID: 35210172. doi:10.1016/j.preteyeres.2022.101053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。